Future Oncology

(ISSN: 1479-6694, 1744-8301)

This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.

Articles Available on Medscape

 
 

Table of Contents

From Future Oncology

2019 -

  • Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis. 
  • Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study. 
  • A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas. 
 
 

Journal Information

Mission Statement: Future Oncology provides an important forum as we enter a new era of cancer care.